Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Afazol Grin
2. Ak Con
3. Ak-con
4. Albalon
5. All Clear
6. Clear Eyes
7. Colirio Alfa
8. Hydrochloride, Naphazoline
9. Idril
10. Miraclar
11. Monohydrochloride, Naphazoline
12. Nafazair
13. Naphazoline
14. Naphazoline Monohydrochloride
15. Naphazoline Nitrate
16. Naphcon
17. Naphcon Forte
18. Nitrate, Naphazoline
19. Optazine
20. Pensa, Vasoconstrictor
21. Privin
22. Privine
23. Proculin
24. Siozwo
25. Tele Stulln
26. Tele-stulln
27. Vasoclear
28. Vasocon
29. Vasocon Regular
30. Vasoconstrictor Pensa
31. Vasonit
1. 550-99-2
2. Naphazoline Hcl
3. Albalon
4. Rhinantin
5. Vasocon
6. Opcon
7. Albalon Liquifilm
8. Rhinoperd
9. Stricylon
10. Naphcon
11. Niazol
12. Rinofug
13. Naphcon Forte
14. 2-(1-naphthylmethyl)-2-imidazoline Hydrochloride
15. Clera Hydrochloride
16. Naphazoline Chloride
17. Privine Hydrochloride
18. Prizole Hydrochloride
19. Nafazair
20. Sanorin
21. 2-(1-naphthylmethyl)imidazoline Hydrochloride
22. Naphazoline (hydrochloride)
23. Nsc-35711
24. 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1h-imidazole Hydrochloride
25. 2-(1-naphthylmethyl)-2-imidazoline Monohydrochloride
26. 1h-imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-, Monohydrochloride
27. Mls000028434
28. Chebi:7470
29. Naphazoline Hydrochloride (naphcon)
30. Mz1131787d
31. Smr000058292
32. Vasoclear
33. Coldan
34. 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1h-imidazole;hydrochloride
35. Comfort Eye Drops
36. Degest-2
37. Naphazoliniumchlorid
38. Naphazolini Chloridum
39. Naphthasolium Chloride
40. Chembl1706
41. Clear Eyes
42. Naphazoline Hydrochloride [jan]
43. Hsdb 2174
44. Naphthylmethylimidazolinhydrochlorid
45. Einecs 208-989-2
46. Mfcd00012554
47. Nsc 35711
48. Albacon
49. 2-(1-naphthylmethyl)-4,5-dihydro-1h-imidazole
50. Sr-01000000067
51. Unii-mz1131787d
52. Prestwick_507
53. Albalon (tn)
54. Vasocon (tn)
55. Component Of Nasocon
56. Naphazoline Hydrochloride [usp:jan]
57. 2-imidazoline, 2-(1-naphthylmethyl)-, Monohydrochloride
58. Opera_id_230
59. Ac1lcwb1
60. Surecn1649580
61. Schembl24153
62. Mls001148448
63. Mls002222217
64. Naphazolinehydrochloride
65. Naphazoline Hydrochloride,(s)
66. Spectrum1500424
67. 2-(1-naphthylmethyl)-2-imidazoline Hydro- Chloride
68. Naphazoline Hcl [inci]
69. 2-imidazoline, Monohydrochloride
70. Dtxsid7045788
71. Molport-000-703-064
72. Hms1568i13
73. Hms1920p11
74. Pharmakon1600-01500424
75. Amy23173
76. Ex-a4103
77. Hy-b0446
78. Nsc35711
79. Ccg-40122
80. Nsc757110
81. S2519
82. Naphazoline Hydrochloride [mi]
83. Akos015908797
84. Naphazoline Hydrochloride (jp17/usp)
85. Nc00523
86. Nsc-757110
87. Naphazoline Hydrochloride [hsdb]
88. Naphazoline Hydrochloride [mart.]
89. Naphazoline Hydrochloride [vandf]
90. Ncgc00094732-01
91. Ncgc00094732-02
92. Ncgc00094732-03
93. Ncgc00094732-04
94. As-16861
95. Naphazoline Hydrochloride [usp-rs]
96. Naphazoline Hydrochloride [who-dd]
97. 2-(naphthalen-1-ylmethyl)-4,5-dihydro-
98. Wln: L66j B1- Bt5m Cn Butj &gh
99. Ft-0603466
100. Lt00114215
101. Lt00233108
102. N0542
103. Sw196701-3
104. C07898
105. D00743
106. H12006
107. Naphazoline Hydrochloride [ep Impurity]
108. Naphazoline Hydrochloride [ep Monograph]
109. Naphazoline Hydrochloride [orange Book]
110. Naphazoline Hydrochloride [usp Monograph]
111. A830484
112. Opcon-a Component Naphazoline Hydrochloride
113. Visine-a Component Naphazoline Hydrochloride
114. Naphcon-a Component Naphazoline Hydrochloride
115. Sr-01000000067-3
116. Vasocon-a Component Naphazoline Hydrochloride
117. W-105587
118. Naphazoline Hydrochloride Component Of Opcon-a
119. Naphazoline Hydrochloride Component Of Visine-a
120. Q27887678
121. Naphazoline Hydrochloride Component Of Naphcon-a
122. Naphazoline Hydrochloride Component Of Vasocon-a
123. 4,5-dihydro-2-(1-naphthylmethyl)-1h-imidazole Hydrochloride
124. 1h-imidazole,5-dihydro-2-(1-naphthalenylmethyl)-, Monohydrochloride
125. Hydron;2-(naphthalen-1-ylmethyl)-4,5-dihydro-1h-imidazole;chloride
126. 1h-imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-, Hydrochloride (1:1)
127. Naphazoline Hydrochloride, European Pharmacopoeia (ep) Reference Standard
128. Naphazoline Hydrochloride, United States Pharmacopeia (usp) Reference Standard
1. Naphazoline
| Molecular Weight | 246.73 g/mol |
|---|---|
| Molecular Formula | C14H15ClN2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 2 |
| Exact Mass | 246.0923762 g/mol |
| Monoisotopic Mass | 246.0923762 g/mol |
| Topological Polar Surface Area | 24.4 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 272 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Naphazoline hydrochloride |
| Drug Label | Naphazoline Hydrochloride, an ocular vasoconstrictor, is an imidazoline derivative sympathomimetic amine. It occurs as a white, odorless crystalline powder having a bitter taste and is freely soluble in water and in alcohol. The active ingredient is... |
| Active Ingredient | Naphazoline hydrochloride |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | 0.1% |
| Market Status | Prescription |
| Company | Akorn |
| 2 of 2 | |
|---|---|
| Drug Name | Naphazoline hydrochloride |
| Drug Label | Naphazoline Hydrochloride, an ocular vasoconstrictor, is an imidazoline derivative sympathomimetic amine. It occurs as a white, odorless crystalline powder having a bitter taste and is freely soluble in water and in alcohol. The active ingredient is... |
| Active Ingredient | Naphazoline hydrochloride |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | 0.1% |
| Market Status | Prescription |
| Company | Akorn |
Adrenergic alpha-Agonists; Nasal Decongestants
National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)
Naphazoline is applied topically to the conjunctiva to temporarily relieve congestion, itching, and minor irritation. Ocular decongestants are ineffective in the treatment of delayed hypersensitivity reactions such as contact dermatoconjunctivitis. The vasoconstrictor effects of naphazoline may be used during some ocular diagnostic procedures, but some clinicians prefer phenylephrine to naphazoline for this use.
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 2823
Ophthalmic solutions containing naphazoline in combination with antihistamines such as antazoline phosphate or pheniramine maleate and/or astringents such as zinc sulfate are commercially available. In the concentrations usually employed, zinc sulfate is a relatively ineffective antiseptic and may promote vasodilation.
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 2824
Adrenergic (vasoconstrictor); decongestant.
O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., 2001., p. 1142
Naphazoline hydrochloride (0.1%), an imidazole derivative with preferential alpha-2 activity, /was instilled/ in 17 eyes of 12 patients with myopathic ptosis due to involvement of the levator palpebrae superioris, in the attempt to selectively stimulate Muller's smooth muscle. Naphazoline significantly widened the palpebral fissure with little change in pupillary diameter and no significant change in ocular pressure, visual acuity and near point determination. However, a reduction of the effect, probably due to tachyphylaxis, was noticed when using naphazoline regularly several times a day for few weeks. In conclusion naphazoline has powerful cosmetical and functional effects in mild to moderate myopathic ptosis above all if taken occasionally.
PMID:8503264 Uncini A et al; Acta Neurol Scand 87 (4): 322-4 (1993)
Ophthalmic use of naphazoline may occasionally cause systemic sympathomimetic effects such as headache, hypertension, cardiac irregularities, nervousness, nausea, dizziness, weakness, and sweating.
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 2824
Use of naphazoline in the eye may cause blurred vision, mild transient stinging and/or irritation, mydriasis, and increased or decreased intraocular pressure. Conjunctival application of naphazoline, especially when high concentrations are used in geriatric patients, may liberate pigment granules, presumably from the iris. Rebound congestion, characterized by reactive hyperemia frequently occurs with prolonged use and may result in overuse of the drug. Prolonged use of the drug should be avoided for these reasons.
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 2824
The incidence of serious adverse effects is low in patients receiving therapeutic dosages of ophthalmic solutions of naphazoline hydrochloride. When naphazoline hydrochloride is used in combination preparations, the cautions applicable to each ingredient in the formulation must be observed. Excessive dosage and/or prolonged or too frequent use may irritate the conjunctiva and, especially in children, cause adverse systemic effects.
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 2824
Naphazoline hydrochloride ophthalmic solution should be used with caution in patients with hypertension, cardiovascular abnormalities, diabetes mellitus, hyperthyroidism, infection, or injury.
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 2824
For more Drug Warnings (Complete) data for NAPHAZOLINE HYDROCHLORIDE (14 total), please visit the HSDB record page.
Adrenergic alpha-Agonists
Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)
Nasal Decongestants
Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) (See all compounds classified as Nasal Decongestants.)
Following topical application of naphazoline hydrochloride solutions to the conjunctiva, local vasoconstriction usually occurs within 10 minutes and may persist for 2-6 hours. Occasionally, enough naphazoline may be absorbed to produce systemic effects. Information on the distribution and elimination of the drug in humans is not available
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 2824
Naphazoline constricts the vascular system of the conjunctiva. It is presumed that this effect is due to direct stimulation action of the drug upon the alpha-adrenergic receptors in the arterioles of the conjunctiva, resulting in decreased conjunctival congestion.
Physician's Desk Reference for Ophthalmic Medicines. 35rd Edition.Thomson PDR. Montvale, NJ. p. 219 (2006)
The mechanism of action of naphazoline has not been conclusively determined. Most pharmacologists believe that the drug directly stimulates alpha-adrenergic receptors of the sympathetic nervous system and exerts little or no effect on beta-adrenergic receptors. Following topical application of naphazoline to the conjunctiva, small arterioles are constricted and conjunctival congestion is temporarily relieved, but reactive hyperemia may occur. The drug also may produce mydriasis when applied to the conjunctiva, but this effect is usually minimal with the concentrations used as ocular decongestants.
McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 2824
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35833
Submission : 2021-04-29
Status : Active
Type : II
Certificate Number : CEP 2022-117 - Rev 00
Issue Date : 2023-11-27
Type : Chemical
Substance Number : 730
Status : Valid
Date of Issue : 2025-02-27
Valid Till : 2028-02-26
Written Confirmation Number : WC-0511
Address of the Firm :
NDC Package Code : 73435-014
Start Marketing Date : 2021-11-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Date of Issue : 2025-02-27
Valid Till : 2028-02-26
Written Confirmation Number : WC-511n
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-07-02
Pay. Date : 2013-06-24
DMF Number : 10667
Submission : 1994-01-12
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40694
Submission : 2024-11-28
Status : Active
Type : II
NDC Package Code : 82133-111
Start Marketing Date : 2025-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32793
Submission : 2018-04-16
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32465
Submission : 2018-01-30
Status : Active
Type : II
Certificate Number : CEP 2019-188 - Rev 02
Issue Date : 2024-09-30
Type : Chemical
Substance Number : 730
Status : Valid
Date of Issue : 2022-08-11
Valid Till : 2025-08-15
Written Confirmation Number : WC-0225
Address of the Firm :
NDC Package Code : 42571-310
Start Marketing Date : 2017-11-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Eltek Pharmachem Co., Ltd.
Registration Date : 2022-02-24
Registration Number : 20220224-211-J-1242
Manufacturer Name : Micro Labs Limited
Manufacturer Address : Plot No.43-45, KIADB, Bommasandra, Industrial Area, 4th Phase Anekal Taluk, Bengaluru-560 105, India

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9934
Submission : 1992-10-30
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35833
Submission : 2021-04-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23642
Submission : 2010-03-12
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40694
Submission : 2024-11-28
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9934
Submission : 1992-10-30
Status : Inactive
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2013-07-02
Pay. Date : 2013-06-24
DMF Number : 10667
Submission : 1994-01-12
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32465
Submission : 2018-01-30
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9709
Submission : 1992-06-04
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32793
Submission : 2018-04-16
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Certificate Number : CEP 2022-117 - Rev 00
Status : Valid
Issue Date : 2023-11-27
Type : Chemical
Substance Number : 730
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2021-445 - Rev 01
Status : Valid
Issue Date : 2024-03-22
Type : Chemical
Substance Number : 730

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2019-188 - Rev 02
Status : Valid
Issue Date : 2024-09-30
Type : Chemical
Substance Number : 730

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Naphazoline Hydrochloride IH/USP/Ph.Eur
Date of Issue : 2025-02-27
Valid Till : 2028-02-26
Written Confirmation Number : WC-511n
Address of the Firm : Plot No. 80A, Road No.5, Jawaharlal Nehru Pharma City, E. Bonangi (V), Parawada ...
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Naphazoline Hydrochloride IH/USP/Ph.Eur
Date of Issue : 2025-02-27
Valid Till : 2028-02-26
Written Confirmation Number : WC-0511
Address of the Firm : Plot No. 80A, Road No.5, Jawaharlal Nehru Pharma City, E. Bonangi (V), Parawada ...
Naphazoline Hydrochloride Ph. Eur
Date of Issue : 2022-08-11
Valid Till : 2025-08-15
Written Confirmation Number : WC-0225
Address of the Firm : Plot No. 43 to 45, KIADB, Bommasandra Industrial area, 4th phase, Anekal taluk, ...

Naphazoline Hydrochloride EP/BP
Date of Issue : 2022-07-27
Valid Till : 2025-07-26
Written Confirmation Number : WC-0531
Address of the Firm : Plot No. D-90/3 TTC IND Area, MIDC Turbhe, Navi Mumbai- 400705,Taluka: Pawvane, ...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Registrant Name : Eltek Pharmachem Co., Ltd.
Registration Date : 2022-02-24
Registration Number : 20220224-211-J-1242
Manufacturer Name : Micro Labs Limited
Manufacturer Address : Plot No.43-45, KIADB, Bommasandra, Industrial Area, 4th Phase Anekal Taluk, Bengaluru...

Registrant Name : Masung LS Co., Ltd.
Registration Date : 2025-06-24
Registration Number : 20250624-211-J-1939
Manufacturer Name : SMS Lifesciences India Limit...
Manufacturer Address : Unit-1, Sy.No. 180/2, Kazipally Village, Jinnaram Mandal, Sangareddy, Telangana 50231...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
NDC Package Code : 73435-014
Start Marketing Date : 2021-11-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 82133-111
Start Marketing Date : 2025-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 62668-6900
Start Marketing Date : 2009-08-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 42571-310
Start Marketing Date : 2017-11-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 72375-0014
Start Marketing Date : 2024-12-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
About the Company : Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-appro...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.
About the Company : Laboratorium Ofichem is a GMP-certified and FDA-approved API manufacturer with state-of-the-art development and production facilities in the Netherlands. We develop and manufacture...
About the Company : Pharm-Rx has earned an outstanding reputation since its establishment in 1991, serving as a reputable importer and distributor of active ingredients to the pharmaceutical, nutritio...
About the Company : BIOTECHNICA DWC LLC has carved a niche for itself in providing value added compliance, regulatory qualification, project management and GDP guidance services to pharma companies al...

About the Company : Farmak International is a leading GMP EU certified pharmaceutical manufacturer in Ukraine established in 1925 with FDA inspected site for production of food supplement. Company spe...

About the Company : Flax Laboratories was established by a group of young and experienced professionals with the specific objective to develop and produce complex, small volume, technology driven bulk...

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

About the Company : Micro Labs Limited is a diversified healthcare company with cutting-edge R&D, advanced manufacturing facilities, and a strong distribution network. It ranks among India's top pharm...

About the Company : Established in 1997, the PRECISE Group is a respected pharmaceutical company in India with an annual turnover of USD 40 million. Backed by a skilled regulatory team, a dedicated fo...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Tusamitamab Ravtansine is a Antibody-drug Conjugate drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Neoplasms.
Lead Product(s): Tusamitamab Ravtansine,Dexamethasone,Naphazoline Hydrochloride,Diphenhydramine
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Antibody-drug Conjugate
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 27, 2017
Lead Product(s) : Tusamitamab Ravtansine,Dexamethasone,Naphazoline Hydrochloride,Diphenhydramine
Therapeutic Area : Oncology
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors
Details : Tusamitamab Ravtansine is a Antibody-drug Conjugate drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Neoplasms.
Product Name : Undisclosed
Product Type : Antibody-drug Conjugate
Upfront Cash : Inapplicable
October 27, 2017
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Alcaftadine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Conjunctivitis, Allergic.
Lead Product(s): Alcaftadine,Naphazoline Hydrochloride,Pheniramine Maleate
Therapeutic Area: Ophthalmology Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Miscellaneous
Sponsor: Milton M. Hom
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 11, 2011
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Alcaftadine,Naphazoline Hydrochloride,Pheniramine Maleate
Therapeutic Area : Ophthalmology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Milton M. Hom
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Tolerability Between Two Allergy Drops
Details : Alcaftadine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Conjunctivitis, Allergic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 11, 2011
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Naphazoline is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hyperemia.
Lead Product(s): Naphazoline Hydrochloride,Hydroxypropyl Methyl Cellulose
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 22, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Naphazoline Hydrochloride,Hydroxypropyl Methyl Cellulose
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Tolerability of PRO-185
Details : Naphazoline is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hyperemia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 22, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Naphazoline is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Influenza, Human.
Lead Product(s): Naphazoline Hydrochloride,Pheniramine Maleate,D-Panthenol
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 15, 2012

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Naphazoline Hydrochloride,Pheniramine Maleate,D-Panthenol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Naphazoline is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Influenza, Human.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 15, 2012

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : ALBALON
Dosage Form : DROPS
Dosage Strength : 0.1%/W/V
Packaging : 15ML
Approval Date :
Application Number : 1147
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : REFRESH EYE ALLERGY RELIEF
Dosage Form : SOLUTION
Dosage Strength : 0.051%
Packaging : 15ML
Approval Date :
Application Number : 2315890
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALBALON
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 80248
Regulatory Info : DISCN
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Murine Clear Eyes
Dosage Form : OPD
Dosage Strength : 0.12mg/ml
Packaging : 15X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : OTC
Registration Country : USA
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
Brand Name : NAPHCON-A
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.025%;0.3%
Packaging :
Approval Date : 1994-06-08
Application Number : 20226
Regulatory Info : OTC
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NAPHCON FORTE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.1%
Packaging :
Approval Date : 1982-01-01
Application Number : 80229
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : OTC
Registration Country : USA
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
Brand Name : NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.02675%;0.315%
Packaging :
Approval Date : 2010-09-27
Application Number : 78208
Regulatory Info : OTC
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : OTC
Registration Country : USA
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
Brand Name : OPCON-A
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.02675%;0.315%
Packaging :
Approval Date : 1994-06-08
Application Number : 20065
Regulatory Info : OTC
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NAFAZAIR
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.1%
Packaging :
Approval Date : 1994-05-25
Application Number : 40073
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE
Brand Name : VASOCON-A
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5%;0.05%
Packaging :
Approval Date : 1994-07-11
Application Number : 18746
Regulatory Info : DISCN
Registration Country : USA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : ALBALON
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 80248
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Brand Name : NAPHCON FORTE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.1%
Approval Date : 1982-01-01
Application Number : 80229
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
Brand Name : NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.02675%;0.315%
Approval Date : 2010-09-27
Application Number : 78208
RX/OTC/DISCN : OTC
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : NAFAZAIR
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.1%
Approval Date : 1994-05-25
Application Number : 40073
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : OPCON
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.1%
Approval Date : 1982-01-01
Application Number : 87506
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : NAFAZAIR
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.1%
Approval Date : 1983-04-15
Application Number : 88101
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE
Brand Name : VASOCON-A
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5%;0.05%
Approval Date : 1994-07-11
Application Number : 18746
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : VASOCON
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.1%
Approval Date : 1983-03-24
Application Number : 80235
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : NAPHAZOLINE HYDROCHLORIDE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.1%
Approval Date : 1982-01-01
Application Number : 83590
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
Brand Name : NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.025%;0.3%
Approval Date : 2013-01-24
Application Number : 202795
RX/OTC/DISCN : OTC
RLD : No
TE Code :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Naphazoline Hydrochloride; Tetracaine Hydrochloride
Brand Name : Colirofta Anesthetic
Dosage Form : Solution
Dosage Strength : 5MG; 0.5 MG
Packaging :
Approval Date : 1954-12-01
Application Number : 22414
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Naphazoline Hydrochloride; Antazoline Phosphate
Brand Name : Optialerg
Dosage Form : Solution
Dosage Strength : 5MG; 0.25 MG
Packaging :
Approval Date : 2017-02-14
Application Number : 81752
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Naphazoline Hydrochloride; Antazoline Phosphate
Brand Name : Allergophal
Dosage Form : Solution
Dosage Strength : 0.25MG; 5 MG
Packaging :
Approval Date : 1953-09-01
Application Number : 19763
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Centilux
Dosage Form : Eye Drop Solution
Dosage Strength : 0.25MG
Packaging :
Approval Date : 1968-10-01
Application Number : 46527
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : Turkey
Naphazoline Hydrochloride; Chlorpheniramine Maleate
Brand Name :
Dosage Form : NASAL SPRAY
Dosage Strength : 0.5MG; 5MG
Packaging : 15 Ml/Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : Turkey
Naphazoline Hydrochloride; Chlorpheniramine Maleate
Brand Name :
Dosage Form : EYE AND NOSE DROPS
Dosage Strength : 0.05%; 0.05%
Packaging : 15 Ml/Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : Turkey
Sulfacetamide; Zinc; Naphazoline Hydrochloride; Lidocaine
Brand Name :
Dosage Form : EYE DROPS
Dosage Strength : 30MG; 5MG; 0.05MG; 7MG
Packaging : 10 Ml/Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey

Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Zolina Llorens Eye Drops
Dosage Form : Eye Drop
Dosage Strength :
Packaging :
Approval Date : 1959-01-01
Application Number : 31271
Regulatory Info : Cancelled
Registration Country : Spain

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : ALBALON
Dosage Form : DROPS
Dosage Strength : 0.1%/W/V
Packaging : 15ML
Approval Date :
Application Number : 1147
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : REFRESH EYE ALLERGY RELIEF
Dosage Form : SOLUTION
Dosage Strength : 0.051%
Packaging : 15ML
Approval Date :
Application Number : 2315890
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : NAPHCON A
Dosage Form : SOLUTION
Dosage Strength : 0.025%
Packaging : 15ML/2.5ML
Approval Date :
Application Number : 481408
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : SOOTHE ALLERGY
Dosage Form : DROPS
Dosage Strength : 0.02675%/W/V
Packaging : 3ML/15ML
Approval Date :
Application Number : 750794
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : VISINE FOR ALLERGY WITH ANTIHISTAMINE
Dosage Form : DROPS
Dosage Strength : 0.025%/W/V
Packaging : 15ML
Approval Date :
Application Number : 2242764
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : CLEAR EYES ALLERGY
Dosage Form : LIQUID
Dosage Strength : 0.012%
Packaging : 15ML
Approval Date :
Application Number : 2248059
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : CLEAR EYES
Dosage Form : LIQUID
Dosage Strength : 0.012%
Packaging : 15/30ML
Approval Date :
Application Number : 2248060
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : CLEAR EYES EXTRA STRENGTH REDNESS RELIEF
Dosage Form : SOLUTION
Dosage Strength : 0.03%/W/V
Packaging : 15/30ML
Approval Date :
Application Number : 2360837
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Murine Clear Eyes
Dosage Form : OPD
Dosage Strength : 0.12mg/ml
Packaging : 15X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Naphazoline HCl; Chlorpheniramine Maleate; Zinc Sulphate; Hypromellose API; Benzalkonium Chloride
Brand Name : ANC
Dosage Form : Eye Drop
Dosage Strength : 0.56MG; 0.1MG; 12MG; 2...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Naphazoline HCl; Chlorpheniramine Maleate; Zinc Sulphate; Hypromellose API; Benzalkonium Chloride
Dosage : Eye Drop
Dosage Strength : 0.56MG; 0.1MG; 12MG; 2...
Brand Name : ANC
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Eye Drop
Dosage Strength : 0.0255% W/V
Packaging : 5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 5ml
Regulatory Info : Generic
Dosage : Eye Drop
Dosage Strength : 0.0255% W/V
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Korea
Pheniramine; Naphazoline Hydrochloride
Brand Name : NAZOLIN
Dosage Form : EYE DROP
Dosage Strength : 3MG/ML; 0.25MG/ML
Packaging : 15mL
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 15mL
Regulatory Info : Generic
Pheniramine; Naphazoline Hydrochloride
Dosage : EYE DROP
Dosage Strength : 3MG/ML; 0.25MG/ML
Brand Name : NAZOLIN
Approval Date :
Application Number :
Registration Country : South Korea

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Korea
Aminocaproic Acid; Neostigmine Methyl Sulfate; Naphazoline Hydrochloride; Chlorpheniramine Maleate
Brand Name : EYEFEEL
Dosage Form : EYE DROP
Dosage Strength : 10MG/ML; 0.02MG/ML; 0....
Packaging : 15mL
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 15mL
Regulatory Info : Generic
Aminocaproic Acid; Neostigmine Methyl Sulfate; Naphazoline Hydrochloride; Chlorpheniramine Maleate
Dosage : EYE DROP
Dosage Strength : 10MG/ML; 0.02MG/ML; 0....
Brand Name : EYEFEEL
Approval Date :
Application Number :
Registration Country : South Korea

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Korea
Naphazoline Hydrochloride; Glycerol
Brand Name : MAXIMUM REDNESS RELIEF
Dosage Form : EYE DROP
Dosage Strength : 0.3MG/ML; 5MG/ML
Packaging : 15mL
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 15mL
Regulatory Info : Generic
Naphazoline Hydrochloride; Glycerol
Dosage : EYE DROP
Dosage Strength : 0.3MG/ML; 5MG/ML
Brand Name : MAXIMUM REDNESS RELIEF
Approval Date :
Application Number :
Registration Country : South Korea

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Korea
Glycerol; Naphazoline Hydrochloride
Brand Name : REDNESS RELIEF
Dosage Form : EYE DROP
Dosage Strength : 2.5MG/ML; 0.12MG/ML
Packaging : 15mL
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 15mL
Regulatory Info : Generic
Glycerol; Naphazoline Hydrochloride
Dosage : EYE DROP
Dosage Strength : 2.5MG/ML; 0.12MG/ML
Brand Name : REDNESS RELIEF
Approval Date :
Application Number :
Registration Country : South Korea

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Iran
Brand Name :
Dosage Form : Ophthalmic Drop
Dosage Strength : 0.1%
Packaging : 10 ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 10 ML
Regulatory Info :
Dosage : Ophthalmic Drop
Dosage Strength : 0.1%
Brand Name :
Approval Date :
Application Number :
Registration Country : Iran

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Iran
Brand Name :
Dosage Form : Nasal Spray
Dosage Strength : 0.05%
Packaging : 15 ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 15 ML
Regulatory Info :
Dosage : Nasal Spray
Dosage Strength : 0.05%
Brand Name :
Approval Date :
Application Number :
Registration Country : Iran

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Application : Direct Compression
Excipient Details : DC SIM 100 is a directly compressible simethicone powder used for antacid and anti-gas tablets.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Application : Topical
Excipient Details : Boric acid is used as an antimicrobial preservative in topical formulations such as creams and ointments.
Pharmacopoeia Ref : EP
Technical Specs : 99.9 % Boric Acid (H3BO3)
Ingredient(s) : Boric Acid Excipient
Dosage Form : Solution
Grade : Oral
Brand Name : CAVAMAX® W7 PHARMA
Application : Solubilizers
Excipient Details : Cavamax W7 Pharma is used as a solubilizer in pharmaceutical liquid dosage forms such as solutions.
Dosage Form : Tablet
Grade : Oral
Application : Emulsifying Agents
Excipient Details : HDK N20 Pharma is used as a pharmaceutical emulsifying agent in tablets, capsules, syrups, and solutions.
Dosage Form : Suspension
Grade : Oral, Topical
Application : Rheology Modifiers
Excipient Details : HPMC 60HD4000 is used as thickener and viscosity modifier in oral solid, liquid and topical dosage forms.
Dosage Form : Suspension
Grade : Oral
Dosage Form : Suspension
Grade : Topical
Application : Rheology Modifiers
Excipient Details : Silfoam® SE 2 is used as a thickener and a viscosity modifier in liquid and topical dosage forms.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Capsule
Grade : Oral
Application : Solubilizers
Excipient Details : Complexol-B (Beta Cyclodextrin) is used as a solubilizer, stabilizer and taste masking agent in tablets, syrups, capsules and lozenges.
Pharmacopoeia Ref : USP-NF, BP, IP, EP, DMF, EXCiP...
Technical Specs : NA
Ingredient(s) : Beta-Cyclodextrin
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral, Topical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Ophthalmic Solution
Grade : Biopharma Grade
Brand Name : Calcium Chloride Dihidrat...
Application : Parenteral
Excipient Details : Used as a buffering agent in liquid formulation like ophthalmics, parenterals, pharma/biopharma processes.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Calcium Chloride Dihidrato
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Brand Name : Citric Acid Monohydrate
Application : Thickeners and Stabilizers
Excipient Details : Used as a pH regulator and preservative in many Biological formulations and cell culture media. Also it can be used as a chelating agent.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Citric Acid Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Thickeners and Stabilizers
Excipient Details : Used as a chelating agent in cell culture media, downstream and as a chelator stabilizer in Biopharmaceutical formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Disodium Edetate Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Brand Name : Magnesium Chloride Hexahy...
Application : Parenteral
Excipient Details : Used as a tonicity agent in cell culture in upstream process and injectable formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Magnesium Chloride Hexahydrate Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Brand Name : Potassium Chloride
Application : Parenteral
Excipient Details : Source of potassium and chloride in cell culture, also used as an osmotic regulator.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Potassium Chloride Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Brand Name : Potassium Phosphate, Diba...
Application : Parenteral
Excipient Details : Used as a buffering agent in cell culture, purification processes and injectable formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Potassium Phosphate, Dibasic Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Brand Name : Potassium Phosphate, Mono...
Application : Parenteral
Excipient Details : Used as a buffering agent in cell culture, purification processes and injectable formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Potassium Phosphate Monobasic Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Parenteral
Excipient Details : Used as an osmolarity agent in culture media, tonicity adjuster in ophthalmics and parenterals solutions.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Sodium Chloride Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Brand Name : Trisodium Citrate
Application : Parenteral
Excipient Details : Used as a buffering agent in purification process during downstream and in the final formulation.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Trisodium Citrate Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Surfactant & Foaming Agents
Excipient Details : Used as surfactant agent in cell culture media, in protein purification and in injectable formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Polysorbate 80
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Inhalation
Grade : Inhalation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Ophthalmic Solution
Grade : Ophthalmic and Nasal
Brand Name : Benzalkonium Chloride
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Benzalkonium Chloride Excipient
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Oral, Parenteral
Brand Name : Benzalkonium Chloride 50%...
Application : Solubilizers
Excipient Details : A&C’s Benzalkonium Chloride 50% is a preservative which meets the NF monograph. It acts as a quarternary ammonium salt.
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Parenteral and Nasal
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Calcium Chloride Dihidrato
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Hydrochloric Acid NF
Application : Parenteral
Excipient Details : A&C's Hydrochloric Acid NF is used as a low pH neutralizing agent for pharmaceutical applications.
Excipients Web Link
Dosage Form : Capsule
Grade : Oral
Brand Name : Polysorbate 80 Multi-Comp...
Application : Solubilizers
Excipient Details : A & C's Polysorbate 80 multi-compendial is an excipient which meets USP-NF, EP, BP and JP monographs.
Excipients Web Link
Dosage Form : Capsule
Grade : Oral
Brand Name : Polysorbate 80 NF
Application : Solubilizers
Excipient Details : A & C's Polysorbate 80 is an excipient which meets the NF monograph.
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Potassium Chloride
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Potassium Chloride Excipient
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : POTASSIUM DIHYDROGEN PHOS...
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Potassium Phosphate Monobasic Excipient
Excipients Web Link
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Brand Name : Potassium Phosphate, Mono...
Application : Topical
Excipient Details : A & C's Potassium phosphate monobasic multi-compendial is an excipient which meets the USP-NF, EP and JP specifications.
Pharmacopoeia Ref : NF
Technical Specs : Not Available
Ingredient(s) : Potassium Phosphate Monobasic Excipient
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Sodium Chloride USP
Application : Parenteral
Excipient Details : A & C's Sodium Chloride is an excipient meeting the USP monograph.
Excipients Web Link
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : Solubilizing agents and Stabilizers.
Dosage Form : Capsule
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Tablet film coating, binders , main material of plant capsules.
Pharmacopoeia Ref : USP/BP/EP/CP
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Emulsifying Agents
Excipient Details : Glidant; Emulsion Stabilizer; Anti-caking Agent.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Softgel Capsule
Grade : Not Available
Application : Solubilizers
Excipient Details : Nonionic solubilizer, emulsifier and co-emulsifier
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : Citric acid monohydrate occurs as colorless or translucent crystals, or as a white crystalline, effervescent powder.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Citric Acid Excipient
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Granule / Pellet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Colorcoat FC4S is used as a film coating agednt in various OSDs.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Granule / Pellet
Grade : Not Available
Brand Name : Colorcoat FC4S(Clear)
Application : Coating Systems & Additives
Excipient Details : Transparent Coating
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Colorcoat FC4W is used as a film coating agednt in various OSDs.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Granule / Pellet
Grade : Not Available
Brand Name : Colorcoat FC4W(Clear)
Application : Coating Systems & Additives
Excipient Details : Transparent Coating
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Colorcoat FC4WS is used as a film coating agednt in various OSDs.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Colorcoat MB4S is used as a film coating agednt in various OSDs.
Dosage Form : Granule / Pellet
Grade : Not Available
Brand Name : Colorcoat MB4S(Clear)
Application : Coating Systems & Additives
Excipient Details : Transparent Coating
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Moisture Barrier Coating
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Colorcoat SC4S is used as a coating agent in various OSDs.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Colorcoat SC4W is used as a coating agent in various OSDs.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Not Available
Brand Name : Hydroxypropyl Methyl Cell...
Application : Coating Systems & Additives
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Market Place
Reply
25 Nov 2025
Reply
17 Sep 2025
Reply
13 Dec 2024
Reply
25 Oct 2024
Reply
24 Sep 2024
Reply
06 Mar 2024
Reply
12 Jan 2024
Reply
17 Jun 2023
Reply
28 Jan 2023
Reply
29 Aug 2019
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
18
PharmaCompass offers a list of Naphazoline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Naphazoline Hydrochloride manufacturer or Naphazoline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Naphazoline Hydrochloride manufacturer or Naphazoline Hydrochloride supplier.
PharmaCompass also assists you with knowing the Naphazoline Hydrochloride API Price utilized in the formulation of products. Naphazoline Hydrochloride API Price is not always fixed or binding as the Naphazoline Hydrochloride Price is obtained through a variety of data sources. The Naphazoline Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Naphazoline HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naphazoline HCl, including repackagers and relabelers. The FDA regulates Naphazoline HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naphazoline HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Naphazoline HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Naphazoline HCl supplier is an individual or a company that provides Naphazoline HCl active pharmaceutical ingredient (API) or Naphazoline HCl finished formulations upon request. The Naphazoline HCl suppliers may include Naphazoline HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Naphazoline HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Naphazoline HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Naphazoline HCl active pharmaceutical ingredient (API) in detail. Different forms of Naphazoline HCl DMFs exist exist since differing nations have different regulations, such as Naphazoline HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Naphazoline HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Naphazoline HCl USDMF includes data on Naphazoline HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Naphazoline HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Naphazoline HCl suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Naphazoline HCl Drug Master File in Korea (Naphazoline HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Naphazoline HCl. The MFDS reviews the Naphazoline HCl KDMF as part of the drug registration process and uses the information provided in the Naphazoline HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Naphazoline HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Naphazoline HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Naphazoline HCl suppliers with KDMF on PharmaCompass.
A Naphazoline HCl CEP of the European Pharmacopoeia monograph is often referred to as a Naphazoline HCl Certificate of Suitability (COS). The purpose of a Naphazoline HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Naphazoline HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Naphazoline HCl to their clients by showing that a Naphazoline HCl CEP has been issued for it. The manufacturer submits a Naphazoline HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Naphazoline HCl CEP holder for the record. Additionally, the data presented in the Naphazoline HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Naphazoline HCl DMF.
A Naphazoline HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Naphazoline HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Naphazoline HCl suppliers with CEP (COS) on PharmaCompass.
A Naphazoline HCl written confirmation (Naphazoline HCl WC) is an official document issued by a regulatory agency to a Naphazoline HCl manufacturer, verifying that the manufacturing facility of a Naphazoline HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Naphazoline HCl APIs or Naphazoline HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Naphazoline HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Naphazoline HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Naphazoline HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Naphazoline HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Naphazoline HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Naphazoline HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Naphazoline HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Naphazoline HCl suppliers with NDC on PharmaCompass.
Naphazoline HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Naphazoline HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Naphazoline HCl GMP manufacturer or Naphazoline HCl GMP API supplier for your needs.
A Naphazoline HCl CoA (Certificate of Analysis) is a formal document that attests to Naphazoline HCl's compliance with Naphazoline HCl specifications and serves as a tool for batch-level quality control.
Naphazoline HCl CoA mostly includes findings from lab analyses of a specific batch. For each Naphazoline HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Naphazoline HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Naphazoline HCl EP), Naphazoline HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Naphazoline HCl USP).